Slide background
Slide background

Rapporto ECHA: Impatti socioeconomici delle autorizzazioni REACH

ID 4634 | | Visite: 2895 | Documenti Chemicals ECHAPermalink:

Report: ECHA’s scrutiny has a profound impact on authorisation decisions

Helsinki, 18 September 2017

According to ECHA’s report the requirements for authorisation have introduced stricter controls of use and have therefore reduced risks from harmful chemicals to workers and the population at large. They have often led to early substitution to safer alternatives. Where applicants made a convincing case that substitution was not possible the recommended authorisations permit them to continue using substances of very high concern and to avoid substantial costs to society.

The authorisation system has entailed costs to applicants and regulatory authorities, but the benefits outweigh the remaining risks, based on ECHA’s analysis of the first 100 applications for authorisation submitted and evaluated by the end of 2016.

The authorisation requirements as well as the reputational issues of continued use of substances of very high concern (SVHCs) have driven companies to substitute hazardous substances with safer alternatives as witnessed by the non-receipt of applications for seven substances on the Authorisation list.

Substitution of substances on the REACH Authorisation List is taking place. No applications were received for seven substances and several applications contained planned substitution activities.   

Three findings stand out:

- Whilst the remaining risks associated with the continued use of SVHCs are important, the risk reductions brought about by the authorisation system have reduced the exposure to harmful chemicals of workers and the population at large. Thereby, the authorisation system has helped to lower the burden of occupational and other diseases in the EU.

- The aggregate benefit of authorisations (i.e. the costs that applicants, their clients and society as a whole would have to bear if the authorisations had not been granted) were estimated to outweigh the remaining monetised risks to human health and the environment by on average a factor of 15 to 1. This ratio varied a lot from one application to another.

- While ECHA’s scientific committees recommended to the European Commission that all the authorisations be granted, they suggested additional conditions and/or monitoring requirements in two-thirds of the uses. Furthermore, they recommended that the review periods be – on average – 2.5 years shorter than proposed by the applicants. Thus, the scientific scrutiny of the applications manifests itself in the opinion-making process.

The authorisation title of the REACH Regulation is a new way of approaching the management of hazardous chemicals, which incentivises firms in the European Union (EU) to substitute away from SVHCs where this is feasible.

In particular, SVHCs listed under Annex XIV to REACH must not be used after a specified sunset date unless a user or their supplier (e.g. the manufacturer or importer of the substance) hold an authorisation.

For substances for which a threshold in accordance with Annex I to REACH was established authorisations must be granted if the risk to human health or the environment from the use applied for is adequately controlled. Authorisations for substances for which it is not possible to determine a threshold may be granted if suitable alternatives to the specific use of the substance are not available and the applicant can credibly show that the socio-economic benefits of continuing its SVHC use beyond the sunset date outweigh the associated risk to human health and the environment.

The REACH authorisation title provides a flexible policy tool to manage the risks associated with the use of SVHCs. Together with EU Member States, the European Commission adds substances to Annex XIV to REACH. This ‘authorisation list’ includes substances which:

(i) are carcinogenic, mutagenic or toxic to reproduction (CMR);
(ii) are persistent, bioaccumulative and toxic (PBT) or very persistent and very bioaccumulative (vPvB); or
(iii) give rise to an equivalent level of concern (e.g. endocrine disrupters).

Firms, in turn, decide whether they wish to use a specific substance after the sunset date — and thus apply for authorisation on their own or under the umbrella of an upstream application — or discontinue the use of the substance.

ECHA and its scientific committees then examine the claims made by the applicants in their applications and forward an opinion on each application to the European Commission, which then decides together with the Member States whether and for how long an authorisation will be granted.

As of May 2017, ECHA had received 115 applications for authorisation for 199 of some 20 different SVHCs. Each of these applications includes a specification of the substance and the use for which authorisation was applied for, supported by a chemical safety report (CSR), an analysis of alternatives (AoA) and a socio-economic analysis (SEA).

ECHA’s Committee for Risk Assessment (RAC) assesses the risks to human health and the environment arising from the specific use of the substance as well as the appropriateness and effectiveness of the risk management measures as described in the CSR. ECHA’s Committee for Socio-economic Analysis (SEAC) examines the applicant’s report on the availability and suitability of alternatives for the use applied for and assesses the socio-economic consequences of the authorisation decision. RAC and SEAC then provide a joint opinion to the European Commission for supporting regulatory decisions.

Fonte: ECHA


Candidate list ECHA: Sostanze estremamente preoccupanti SVHC

ebook Regolamento REACH

Tags: Chemicals Abbonati Chemicals Candidate list Guida ECHA

Articoli correlati

Ultimi archiviati Chemicals

Decreto 16 Aprile 2021
Mag 05, 2021 17

Decreto 16 aprile 2021 | Suppl. 10.4 Farmacopea Europea 10ª Ed.

Decreto 16 aprile 2021 Entrata in vigore dei testi, nelle lingue inglese e francese, pubblicati nel Supplemento 10.4 della Farmacopea europea 10ª edizione. (GU n.106 del 05.05.2021) ...[box-info]Aggiornamenti10.0 Decreto 9 febbraio 2020 | 10ª edizione della Farmacopea Europea10.1 Decreto 2 aprile… Leggi tutto
Decisione UE 2021 727
Mag 05, 2021 22

Decisione (UE) 2021/727

Decisione (UE) 2021/727 del Consiglio del 29 aprile 2021 relativa alla presentazione, a nome dell’Unione europea, di proposte di modifica degli allegati A e B della convenzione di Minamata sul mercurio riguardanti i prodotti con aggiunta di mercurio e i processi di fabbricazione che comportano… Leggi tutto
Mag 04, 2021 20

Regolamento (UE) n. 518/2013

Regolamento (UE) n. 518/2013 Regolamento (UE) n. 518/2013 del Consiglio, del 13 maggio 2013, che adatta il regolamento (CE) n. 1107/2009 del Parlamento europeo e del Consiglio in ragione dell'adesione della Repubblica di Croazia (GU L 158 del 10.6.2013) Collegati[box-note]Regolamento (CE)… Leggi tutto
Mag 04, 2021 18

Regolamento (UE) 2018/605

Regolamento (UE) 2018/605 Regolamento (UE) 2018/605 della Commissione, del 19 aprile 2018, che modifica l'allegato II del regolamento (CE) n. 1107/2009 stabilendo criteri scientifici per la determinazione delle proprietà di interferente endocrino. (GU L 101 del 20.4.2018)… Leggi tutto
Mag 04, 2021 43

Regolamento (UE) 2015/2283

Regolamento (UE) 2015/2283 Regolamento (UE) 2015/2283 del Parlamento europeo e del Consiglio, del 25 novembre 2015, relativo ai nuovi alimenti e che modifica il regolamento (UE) n. 1169/2011 del Parlamento europeo e del Consiglio e abroga il regolamento (CE) n. 258/97 del Parlamento europeo e del… Leggi tutto
Mag 04, 2021 48

Regolamento (CE) n. 1331/2008

Regolamento (CE) n. 1331/2008 Regolamento (CE) n. 1331/2008 del Parlamento europeo e del Consiglio, del 16 dicembre 2008, che istituisce una procedura uniforme di autorizzazione per gli additivi, gli enzimi e gli aromi alimentari. (GU L 354 del 31.12.2008) In allegato: - Testo nativo- Testo… Leggi tutto
Mag 03, 2021 26

Regolamento (UE) 1282/2011

Regolamento (UE) 1282/2011 Regolamento (UE) n. 1282/2011 della Commissione del 28 novembre 2011 che modifica e corregge il regolamento (UE) n. 10/2011 della Commissione riguardante i materiali e gli oggetti di materia plastica destinati a venire a contatto con i prodotti alimentari. (GU L 328 del… Leggi tutto
Mag 03, 2021 28

Regolamento (UE) 1183/2012

Regolamento (UE) 1183/2012 Regolamento (UE) n. 1183/2012 della Commissione del 30 novembre 2012 che modifica e corregge il regolamento (UE) n. 10/2011 riguardante i materiali e gli oggetti di materia plastica destinati a venire a contatto con i prodotti alimentari. (GU L 338 del 12.12.2012)… Leggi tutto
Mag 03, 2021 30

Regolamento (UE) 865/2014

Regolamento (UE) 865/2014 Regolamento (UE) n. 865/2014 della Commissione dell'8 agosto 2014 che corregge la versione spagnola del regolamento (UE) n. 10/2011 riguardante i materiali e gli oggetti di materia plastica destinati a venire a contatto con i prodotti alimentari. (GU L 238 del 9.8.2014)… Leggi tutto
Mag 03, 2021 27

Regolamento di esecuzione (UE) 321/2011

Regolamento di esecuzione (UE) 321/2011 Regolamento di esecuzione (UE) n. 321/2011 della Commissione del 1 aprile 2011 che modifica il regolamento (UE) n. 10/2011 per quanto riguarda le restrizioni d'uso del bisfenolo A nei biberon di plastica. (GU L 87 del 2.4.2011) Collegati[box-note]Regolamento… Leggi tutto

Più letti Chemicals

Regolamento  CE  n  178 2002
Mag 04, 2021 44510

Regolamento (CE) N. 178/2002

Regolamento (CE) n. 178/2002 Regolamento (CE) n. 178/2002 del Parlamento europeo e del Consiglio del 28 gennaio 2002 che stabilisce i principi e i requisiti generali della legislazione alimentare, istituisce l'Autorità europea per la sicurezza alimentare e fissa procedure nel campo della sicurezza… Leggi tutto